期刊文献+

培哚普利和氯沙坦抗实验性肝纤维化的研究 被引量:10

Effect of ACE-I and AT-1 receptor blocker on the progression of CCl_4-inducing rat hepatic fibrogenesis
原文传递
导出
摘要 目的 探讨血管紧张素转化酶抑制剂 (ACE I)培哚普利和血管紧张素Ⅱ 1型受体 (AT 1受体 )阻滞剂氯沙坦对实验性肝纤维化的影响。方法 Wistar大鼠 6 0只 ,随机分为 4组 ,模型组 :4 0 %CCl4油 0 2 5ml/10 0mg皮下注射 ,每周 2次 ;培哚普利治疗组 :培哚普利 2mg/kg灌胃 ,每日 1次。氯沙坦治疗组 :氯沙坦 5 0mg/kg灌胃 ,每日 1次。对照组 :橄榄油皮下注射。于第 4、6周取材。光镜下动态观察组织学改变 ;RT PCR检测AT 1受体的表达 ;免疫蛋白质印迹检测AT 1受体、转化生长因子 β1(TGF β1)和血小板衍生生长因 BB(PDGF BB)蛋白的表达 ;明胶酶法测定金属蛋白酶 2(MMP 2 )的活性 ;放免检测血清透明质酸 (HA)、层粘蛋白 (LN)的含量。结果 培哚普利组和氯沙坦组肝纤维化程度和血清HA、LN含量低于模型组 ;培哚普利组和氯沙坦组AT 1受体mRNA和蛋白质表达水平、TGF β1和PDGF BB蛋白质的表达低于模型组 ;模型组MMP 2活性高于培哚普利组和氯沙坦组。结论 培哚普利和氯沙坦对实验性大鼠肝纤维化具有抑制作用。 Objective The aim of the present study was to determine the effects of angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin Ⅱ type 1 receptor (AT-1 receptor) blocker on the progression of rat hepatic fibrosis induced by CCl 4 Methods 60 male wistar rats weighting about 250 g were divided into 4 groups Model group (Mo): The rats were injected with 40% CCl 4 025 ml/100 g subcutaneously three times a week Perindopril group (Pe): The rats were injected with 40% CCl 4 Perindopril, equivalent to 2 mg·kg -1·d -1, was given ig Losartan group (Lo): The rats were injected with 40% CCl 4 Losartan, equivalent to 50 mg·kg -1·d -1, was given ig Control group (Nc): the rats were injected with olive oil only After 4,6 weeks, morphological examination was based on microscopy RT-PCR was utilized to detect gene expression of AT-1 receptor in the liver Meanwhile, the protein expressions of AT-1 receptor, TGF-β1 and PDGF-BB in liver tissue were examined by Western blot The activity of matrix metalloproteinase-2 (MMP-2) was assessed by zymography Serum laminin (LN) and hyaluronic acid (HA) were measured using radioimmunoassays Results RT-PCR and Western blot revealed that there was a up-regulation in AT-1 receptor expression in model group compared with control group Both of perindopril and losartan treatment significantly reduced mean fibrosis score, messenger RNA and protein levels of AT1 receptor, protein levels of TGF-β1 and PDGF-BB, Serum levels of HA and LN, and MMP-2 activity Conclusion These results suggest that angiotensin Ⅱmay play an important role in fibrosis of liver Perindopril and losartan may have inhibiting effects on CCl 4-induced hepatic fibrogenesis of rat
出处 《中华医学杂志》 CAS CSCD 北大核心 2003年第14期1241-1245,共5页 National Medical Journal of China
基金 国家自然科学基金资助项目 ( 3 0 2 70 610 )
关键词 培哚普利 氯沙坦 肝纤维化 动物实验 血管紧张素转化酶抑制剂 血管紧张素Ⅱ1型受体阻滞剂 肝硬化 Liver cirrhosis Renin-angiotensin system Angiotensin Ⅱ Receptor Angiotensin-converting enzyme inhibitors
  • 相关文献

参考文献16

  • 1Brilla CG,Maisch B,Zhou G,et al.Hormonal regulation of cardiac fibroblast function.Eur Heart J, 1995,16 Suppl C:45-50.
  • 2Harris RC, Martinez-Maldonado M. Angiotensin II-mediated renal injury. Miner Electrolyte Metab, 1995,21:328-335.
  • 3Marshall RP, Mcanulty RJ, Laurent GJ, et al. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med, 2000,161:1999-2004.
  • 4Leung P S, Yao X Q, Chan H C, et al. Differential gene expression of angiotensin II receptor subtypes in the epididymides of mature and immature rats. Life sciences, 1998,62:461-468.
  • 5Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol, 1991,13:372-374.
  • 6Kim S, Zhan Y, Izumi Y, et al. In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Arterioscler Thromb Vasc Biol, 2000,20:2539-2545.
  • 7Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol, 1997,29:1947-1958.
  • 8Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med, 2000, 161:1999-2004.
  • 9Hamaguchi A, Kim S, Izumi Y, et al. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. Hypertension, 1999, 34:126-131.
  • 10Kelly DJ, Cox AJ, Tolcos M, et al. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int, 2002, 61:31-39.

二级参考文献4

  • 1吴平生,中华心血管病杂志,1998年,26卷,139页
  • 2Gomez Sanchez E P,Steroids,1996年,61卷,184页
  • 3Oaks M K,J Steroid Biochem Mol Biol,1995年,54卷,193页
  • 4吴平生,梁欣伟,戴云,刘宏,臧燕,郭志刚,张榕华,赖文岩,张远慧,刘伊丽.肾上腺外组织合成醛固酮[J].中华心血管病杂志,1998,26(2):139-141. 被引量:11

共引文献16

同被引文献95

  • 1龚作炯,宋仕玲,黄砚青,阮鹏,张志荣.血管紧张素Ⅱ受体拮抗剂对大鼠肝纤维化的疗效及作用机制[J].肝脏,2004,9(2):97-100. 被引量:3
  • 2余昌胤,蔡志友.美满霉素对大鼠脑缺血再灌注脑组织基质金属蛋白酶表达的影响[J].贵州医药,2006,30(11):983-985. 被引量:6
  • 3黄如训 曾进胜.肾性高血压大鼠脑血管病变的初步观察[J].中国神经精神疾病杂志,1990,16:136-138.
  • 4Powell EE, Edwards-Smith CJ, Hay JL, et al. Host genetic factors influence disease progression in chronic hepatitis C[J].Hepatology, 2000, 31: 828-33.
  • 5Tuncer I, Ozbek H, Ugras S, et al. Anti-fibrogenic effects ofcaptopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis [ J ]. Exp Toxicol Pathol, 2003, 55: 159-66.
  • 6Paizis G, Gilbert RE, Cooper ME, et al. Effect ofangiotensin Ⅱ type 1 receptor blockade on experimental hepatic fibrogenesis [J]. J Hepatol, 2001, 35: 376-85.
  • 7Nie L, Imamura M, Itoh H, et al. Pitavastatin enhances the antifibrogenesis effects of candesartan, an angiotensin Ⅱ receptor blocker, on CCl4-induced liver fibrosis in rats[J]. J UOEH, 2004, 26: 165-77.
  • 8Hellerbrand C, Jobin C, Licato LL. Cytokines induce NF-kappa B in activated but not quiescent rat hepatic satellite cells [J]. Am J Physiol, 1998, 275: G269-78.
  • 9Taub R. Blocking NF-kappa B in the liver: the good and bad news[J]. Hepatology, 1998, 27: 1445-6.
  • 10Li X, Meng Y, Wu PS, et al. Angiotensin Ⅱ and aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat[J]. Regul Pept, 2007, 138: 15-25.

引证文献10

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部